XML 47 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 13 - Stock Based Compensation
12 Months Ended
Jul. 03, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 13. Stock Based Compensation
 
The Plan is administered by the Compensation Committee or such other Board committee (or the entire Board) as may be designated by the Board (the “Committee”). At July 3, 2016, the Company has reserved approximately 10.5 million shares of common stock for issuance, including options previously authorized for issuance under the 1999 Stock Incentive Plan.
 
The amounts of stock-based compensation expense recognized in the periods presented are as follows:
 
   
Years Ended
 
   
July 3, 2016
   
June 28, 2015
   
June 29, 2014
 
   
(in thousands, except per share data)
 
Stock options
  $ 432     $ 459     $ 420  
Restricted stock awards
    5,911       5,503       4,244  
Total
    6,343       5,962       4,664  
Deferred income tax benefit
    1,987       2,087       1,738  
Stock-based compensation expense, net
  $ 4,356     $ 3,875     $ 2,926  
 
 
Stock based compensation expense is recorded within the following line items of operating expenses:
 
   
Years Ended
 
   
July 3, 2016
   
June 28, 2015
   
July 29, 2014
 
   
(in thousands)
 
Marketing and sales
  $ 2,306     $ 1,866     $ 1,261  
Technology and development
    493       392       298  
General and administrative
    3,544       3,704       3,105  
Total
  $ 6,343     $ 5,962     $ 4,664  
 
Stock-based compensation expense has not been allocated between business segments, but is reflected as part of Corporate overhead. (Refer to Note 15. Business Segments).
 
Stock Options
 
The weighted average fair value of stock options on the date of grant, and the assumptions used to estimate the fair value of the stock options using the Black-Scholes option valuation model, were as follows:
 
   
Years ended
 
   
July 3, 2016
(1)
   
June 28, 2015
   
June 29, 2014
 
                         
Weighted average fair value of options granted
    n/a     $ 4.86     $ 3.16  
Expected volatility
    n/a       52 %     61 %
Expected life (in years)
    n/a       7.3       6.6  
Risk-free interest rate
    n/a       1.9 %     1.6 %
Expected dividend yield
    n/a       0.0 %     0.0 %
     
 
(1)
No options were granted during the
fiscal year ended July 3, 2016.
 
The expected volatility of the option is determined using historical volatilities based on historical stock prices. The Company estimated the expected life of options granted based upon the historical weighted average. The risk-free interest rate is determined using the yield available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the option. The Company has never paid a dividend, and as such the dividend yield is 0.0%.
 
The following table summarizes stock option activity during the year ended July 3, 2016:
 
   
 
 
 
 
 
Options
   
 
 
Weighted
Average
Exercise
Price
   
 
Weighted
Average
Remaining
Contractual
Term
(in years)
   
 
 
 
Aggregate
Intrinsic
Value (000s)
 
                                 
Outstanding beginning of period
    3,345,146     $ 2.93                  
Granted
    -     $ -                  
Exercised
    (1,044,255 )   $ 3.36                  
Forfeited/Expired
    (118,657 )   $ 7.33                  
Outstanding end of period
    2,182,234     $ 2.49       4.8     $ 14,236  
                                 
Options vested or expected to vest at end of period
    2,117,259     $ 2.49       4.8     $ 13,821  
Exercisable at July 3, 2016
    1,261,234     $ 2.45       4.6     $ 8,271  
 
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company
’s closing stock price on the last trading day of fiscal 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on July 3, 2016. This amount changes based on the fair market value of the Company’s stock. The total intrinsic value of options exercised for the years ended July 3, 2016, June 28, 2015 and June 29, 2014 was $4.2 million, $3.6 million, and $0.4 million, respectively
.
 
The following table summarizes information about stock options outstanding at July 3, 2016:
 
 
 
 
 
 
 
Options Outstanding
   
Options Exercisable
 
 
 
 
 
Exercise Price
 
 
 
Options
Outstanding
   
Weighted
-
Average
Remaining
Contractual Life
(years)
   
Weighted
-
Average
Exercise
Price
   
 
 
Options
Exercisable
   
Weighted
-
Average
Exercise
Price
 
  $1.69 1.79     1,001,000       4.3     $ 1.79       626,000     $ 1.79  
  $2.22 2.44     42,000       6.3     $ 2.43       42,000     $ 2.43  
  $2.63 2.63     1,010,000       0.9     $ 2.63       508,000     $ 2.63  
  $2.88 10.20     129,234       4.1     $ 6.85       85,234     $ 6.23  
            2,182,234       4.8     $ 2.49       1,261,234     $ 2.45  
 
As of July 3, 2016, the total future compensation cost related to non-vested options not yet recognized in the statement of operations was $1.2 million and the weighted average period over which these awards are expected to be recognized was 2.9 years.
 
Restricted Stock
 
The Company grants shares of Common Stock to its employees that are subject to restrictions on transfer and risk of forfeiture until fulfillment of applicable service conditions and, in certain cases, holding periods (Restricted Stock).
 
The following table summarizes the activity of non-vested restricted stock during the year ended July 3, 2016:
 
   
 
 
Shares
   
Weighted Average
Grant Date Fair
Value
 
                 
Non-vested
– beginning of period
    2,342,052     $ 5.62  
Granted
    1,027,706     $ 9.01  
Vested
    (879,863 )   $ 5.21  
Forfeited
    (472,826 )   $ 8.85  
Non-vested - end of period
    2,017,069     $ 6.78  
 
The fair value of non-vested shares is determined based on the closing stock price on the grant date. As of July 3, 2016, there was $7.4 million of total unrecognized compensation cost related to non-vested restricted stock-based compensation to be recognized over a weighted-average period of 2.1 years.